AOD-9604 Guide

AOD-9604 is a synthetic fragment analog derived from the C-terminal region of human growth hormone, often described around the Tyr-hGH 177-191 sequence. It is marketed heavily around fat-loss claims, but the evidence picture is more mixed and narrower than that marketing suggests. [1][2][5]

The key distinction is safety versus efficacy. Published human safety and tolerability data exist, but fat-loss benefit in humans is not established by the sources available for this profile. Preclinical metabolism findings should not be translated directly into human weight-loss promises. [1][2][5]

Early work studied a synthetic lipolytic domain of human growth hormone. These studies helped frame AOD-9604 as a growth-hormone fragment intended to separate lipid-metabolism effects from full-length growth hormone effects. [1]

Animal work reported effects on lipid metabolism in obese mice and beta-3 adrenergic receptor knockout mice. That is useful preclinical context, but animal metabolic effects cannot be used as proof of human fat loss. [2]

A 2013 human safety paper summarized six randomized, double-blind, placebo-controlled clinical trials involving AOD-9604. The authors focused on safety concerns tied to full-length growth hormone, including IGF-1, glucose tolerance, insulin resistance, and antibodies. [5]

That safety summary should not be overread. A tolerability profile that appears similar to placebo in the studied trials is not the same as proven fat-loss efficacy, and it does not validate unapproved products sold through peptide markets. [5][6]

AOD-9604 also appears in doping and analytical chemistry contexts. A Drug Testing and Analysis paper examined detection and in vitro metabolism, which is a different question from whether a product helps human weight loss. [3]

FDA compounding materials include AOD-9604 in discussions of nominated bulk drug substances that may present significant safety risks. That regulatory context matters for readers evaluating compounded or research-market claims. [6][7]

AOD-9604 is also discussed in sports-doping settings. Readers should not assume that a peptide sold online is legal, allowed in sport, approved for weight loss, or clinically validated for body-composition claims. [8]

Seller claims about purity or COAs address only one part of the problem. They do not establish clinical benefit, route safety, dosing, sterility for injection, or regulatory approval.

There is no Peptides Defined protocol for AOD-9604 dosing, mixing, injection, oral use, or storage. Research and regulatory sources are used here to explain evidence quality, not to instruct use.

If a product is not an approved labeled medicine, seller handling instructions should be treated as product-specific claims rather than official prescribing information. [6]